1640TiP PECATI: A phase II trial to evaluate the efficacy and safety of lenvatinib in combination with pembrolizumab in pretreated advanced b3-thymoma (B3-T) and thymic carcinoma (TC)

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 33; p. S1291
Main Authors Remon Masip, J., Girard, N., Bironzo, P., Novello, S., De Castro Carpeno, J., Bigay-Game, L., Bernabe Caro, R., Greillier, L., Mosquera Martinez, J., Cousin, S., Juan Vidal, O.J., Sampayo-Cordero, M., Besse, B.
Format Journal Article
LanguageEnglish
Published 01.09.2022
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
DOI:10.1016/j.annonc.2022.07.1719